middle.news
How PromarkerEndo Could End Seven-Year Endometriosis Diagnostic Delays
1:47am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How PromarkerEndo Could End Seven-Year Endometriosis Diagnostic Delays
1:47am on Monday 2nd of June, 2025 AEST
Key Points
PromarkerEndo demonstrates high diagnostic accuracy across all endometriosis stages
Single universal blood test with a 'traffic light' risk score system
Study of 704 participants validates test performance, including early-stage disease
Commercial rollout in Australia targeted for Q3 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE